首页> 外文期刊>Radiation oncology >Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy
【24h】

Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy

机译:慢性放射性肠病术后宫颈癌患者的临床特征,结局和危险因素

获取原文

摘要

Background Radical hysterectomy and radiotherapy have long been mainstays of cervical cancer treatment. Early stage cervical cancer (FIGO stage IB1–IIA) is traditionally treated using radical surgery combined with radiotherapy, while locally advanced cervical cancer is treated using radiotherapy alone or chemoradiotherapy. In this retrospective study, we describe and analyse the presenting clinical features and outcomes in our cohort and evaluate possible risk factors for postoperative morbidity in women who underwent surgery for chronic radiation enteropathy (CRE). Methods One hundred sixty-six eligible cervical cancer patients who underwent surgery for CRE were retrospectively identified between September 2003 and July 2014 in a prospectively maintained database. Among them, 46 patients received radical radiotherapy (RRT) and 120 received radical surgery plus radiotherapy (RS?+?RT). Clinical features, postoperative morbidity and mortality, and risk factors for postoperative morbidity were analysed. Results RS?+?RT group patients were more likely to present with RTOG/EORTC grade III late morbidity (76.1 % vs 92.5 %; p?=?0.004), while RRT group patients tended to show RTOG/EORTC grade IV late morbidity (23.9 % vs 7.5 %; p?=?0.004). One hundred forty patients (84.3 %) were treated with aggressive resection (anastomosis 57.8 % and stoma 26.5 %). Overall and major morbidity, mortality and incidence of reoperation in the RRT and RS?+?RT groups did not differ significantly (63 % vs 64.2 % [p?=?1.000], 21.7 % vs 11.7 % [p?=?0.137], 6.5 % vs 0.8 % [p?=?0.065] and 6.5 % vs 3.3 % [p?=?0.360], respectively). However, incidence of permanent stoma and mortality during follow-up was higher in the RRT group than in the RS?+?RT group (44.2 % vs 12.6 % [p?=?0.000] and 16.3 % vs 3.4 % [p?=?0.004], respectively). In multivariate analysis, preoperative anaemia was significantly associated with overall morbidity (p?=?0.015), while severe intra-abdominal adhesion (p?=?0.017), ASA grades III–V (P?=?0.022), and RTOG grade IV morbidity (P?=?0.018) were predicators of major morbidity. Conclusions Radiation-induced late morbidity tended to be severe in the RRT group with more patients suffering RTOG/EORTC grade IV morbidity, while there were no significant differences in postoperative morbidity, mortality and reoperation. Aggressive resection was feasible with acceptable postoperative outcomes. Severe intra-abdominal adhesion, ASA grades III–V and RTOG/EORTC grade IV late morbidity contributed significantly to major postoperative morbidity.
机译:背景技术根治性子宫切除术和放射疗法一直是宫颈癌治疗的主要手段。早期子宫颈癌(FIGO IB1-IIA期)传统上采用根治性手术结合放疗进行治疗,而局部晚期宫颈癌则仅采用放疗或放化疗进行治疗。在这项回顾性研究中,我们描述和分析了我们队列中的临床特征和结局,并评估了接受慢性放射性肠病(CRE)手术的妇女术后发病的可能危险因素。方法2003年9月至2014年7月,在前瞻性维护的数据库中,回顾性分析了166例接受了CRE手术的合格宫颈癌患者。其中,有46例接受了根治性放射治疗(RRT),有120例接受了根治性手术加放射治疗(RS≥+ RT)。分析了临床特征,术后发病率和死亡率,以及术后发病的危险因素。结果RS?+?RT组患者更有可能出现RTOG / EORTC III级晚期发病率(76.1%vs 92.5%; p?=?0.004),而RRT组患者则倾向于显示RTOG / EORTC IV级晚期发病率( 23.9%对7.5%;p≤0.004)。积极切除术治疗了一百四十例患者(占84.3%)(吻合口切除术占57.8%,造口术占26.5%)。 RRT和RS?+?RT组的总体和主要发病率,死亡率和再次手术发生率无显着差异(63%vs. 64.2%[p?=?1.000],21.7%vs. 11.7%[p?=?0.137] ,分别为6.5%与0.8%[p?=?0.065]和6.5%与3.3%[p?=?0.360])。然而,RRT组的永久性气孔发生率和死亡率高于RS?+?RT组(44.2%vs. 12.6%[p?=?0.000]和16.3%vs 3.4%[p?=分别为[0.004])。在多变量分析中,术前贫血与总体发病率显着相关(p?=?0.015),而严重的腹腔内粘连(p?=?0.017),ASA III–V级(P?=?0.022)和RTOG级IV发病率(P≥0.018)是主要发病率的预测指标。结论RRT组的放疗引起的晚期发病趋于严重,RTOG / EORTC IV级发病率更高,而术后发病率,死亡率和再次手术率无显着差异。积极的切除是可行的,术后结果可以接受。严重的腹腔内粘连,ASA III–V级和RTOG / EORTC IV级晚期发病率显着提高了主要的术后发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号